Chimerix to Present at the Morgan Stanley Global Healthcare Conference
September 06 2016 - 8:00AM
Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing
novel antivirals to address unmet medical needs, today announced
that M. Michelle Berrey, M.D., M.P.H, Chief Executive Officer of
Chimerix, will present at the Morgan Stanley Global Healthcare
Conference on Monday, September 12, 2016 at 4:15 p.m. ET at the
Grand Hyatt Hotel in New York City.
A live audio webcast of the presentation will be available on
the Investor Relations section of Chimerix’s website
at http://ir.chimerix.com/events.cfm, where it will be
archived for approximately 90 days.
About Chimerix
Chimerix is a biopharmaceutical company
dedicated to discovering, developing and commercializing novel
antivirals in areas of high unmet medical need. Chimerix's
proprietary lipid conjugate technology has produced brincidofovir
(BCV, CMX001); CMX157, which was licensed to ContraVir
Pharmaceuticals; and earlier-stage clinical candidates, including
CMX669. Chimerix is also advancing a clinical candidate
for norovirus infection, CMX521. For further information, please
visit Chimerix's website, www.chimerix.com.
CONTACT:
Investor Relations:
ir@chimerix.com
or
Jesse Baumgartner
Stern Investor Relations
Jesse@sternir.com
212-362-1200
Media:
Becky Vonsiatsky
W2O Group
bvonsiatsky@w2ogroup.com
413-478-2003
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Chimerix (NASDAQ:CMRX)
Historical Stock Chart
From Apr 2023 to Apr 2024